» Articles » PMID: 30528902

MicroRNA-124 Regulates Fatty Acid and Triglyceride Homeostasis

Overview
Journal iScience
Publisher Cell Press
Date 2018 Dec 12
PMID 30528902
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are part of a complex regulatory network that modulates cellular lipid metabolism. Here, we identify miR-124 as a regulator of triglyceride (TG) metabolism. This study advances our knowledge of the role of miR-124 in human hepatoma cells. Transcriptional profiling of Huh7.5 cells overexpressing miR-124 reveals enrichment for host factors involved in fatty acid oxidation among repressed miRNA targets. In addition, miR-124 down-regulates arylacetamide deacetylase (AADAC) and adipose triglyceride lipase, lipases proposed to mediate breakdown of hepatic TG stores for lipoprotein assembly and mitochondrial β-oxidation. Consistent with the inhibition of TG and fatty acid catabolism, miR-124 expression promotes cellular TG accumulation. Interestingly, miR-124 inhibits the production of hepatitis C virus, a virus that hijacks lipid pathways during its life cycle. Antiviral activity of miR-124 is consistent with repression of AADAC, a pro-viral host factor. Overall, our data highlight miR-124 as a novel regulator of TG metabolism in human hepatoma cells.

Citing Articles

MiR-451a attenuates hepatic steatosis and hepatitis C virus replication by targeting glycerol kinase.

Majumdar S, Chowdhury D, Chakraborty B, Chowdhury A, Datta S, Banerjee S J Transl Med. 2025; 23(1):322.

PMID: 40083012 PMC: 11907786. DOI: 10.1186/s12967-025-06286-9.


Impact of Maternal BPA Exposure during Pregnancy on Obesity in Male Offspring: A Mechanistic Mouse Study of Adipose-Derived Exosomal miRNA.

Huang Z, Niu R, Xu Q, Zhang R, Hu W, Qin Y Environ Health Perspect. 2025; 133(1):17011.

PMID: 39886984 PMC: 11783688. DOI: 10.1289/EHP14888.


HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV.

Cheng Y, Jung J, Guo L, Shuboni-Mulligan D, Chen J, Hu W Brain Behav Immun. 2024; 123:108-122.

PMID: 39260763 PMC: 11624073. DOI: 10.1016/j.bbi.2024.09.011.


Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets.

Mahmoudi A, Jalili A, Butler A, Aghaee-Bakhtiari S, Jamialahmadi T, Sahebkar A J Clin Exp Hepatol. 2024; 14(4):101365.

PMID: 38433957 PMC: 10904918. DOI: 10.1016/j.jceh.2024.101365.


MicroRNA (miR)-124: A Promising Therapeutic Gateway for Oncology.

Gourishetti K, Easwaran V, Mostakim Y, Pai K, Bhere D Biology (Basel). 2023; 12(7).

PMID: 37508353 PMC: 10376116. DOI: 10.3390/biology12070922.


References
1.
Kersten S, Seydoux J, Peters J, Gonzalez F, Desvergne B, Wahli W . Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999; 103(11):1489-98. PMC: 408372. DOI: 10.1172/JCI6223. View

2.
Jopling C, Yi M, Lancaster A, Lemon S, Sarnow P . Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005; 309(5740):1577-81. DOI: 10.1126/science.1113329. View

3.
Krutzfeldt J, Rajewsky N, Braich R, Rajeev K, Tuschl T, Manoharan M . Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. DOI: 10.1038/nature04303. View

4.
Esau C, Davis S, Murray S, Yu X, Pandey S, Pear M . miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006; 3(2):87-98. DOI: 10.1016/j.cmet.2006.01.005. View

5.
Karginov F, Conaco C, Xuan Z, Schmidt B, Parker J, Mandel G . A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A. 2007; 104(49):19291-6. PMC: 2148283. DOI: 10.1073/pnas.0709971104. View